Traditional Chinese medicine for breast cancer treatment: a bibliometric and visualization analysis

Autor: Jun Yuan, Yun Liu, Tiantian Zhang, Cheng Zheng, Xiao Ding, Chuanrong Zhu, Jing Shi, Yi Jing

Publikováno v: Pharmaceutical Biology, Vol 62, Iss 1, Pp 499-512 (2024)

Context The use of traditional Chinese medicine (TCM) for breast cancer patients inhibits tumor cell growth and proliferation, alleviates adverse reactions, and inhibits tumor recurrence and metastasis post-surgery. An assessment of its historical ef

Externí odkaz: https://doaj.org/article/613f8eedcf62425f8e3cd76d901ec7c3

Circular RNA hsa_circ_0004277 Stimulates Malignant Phenotype of Hepatocellular Carcinoma and Epithelial-Mesenchymal Transition of Peripheral Cells

Autor: Lei Liu, Chuanrong Zhu, Shaochuang Wang, Jinsheng Wu, Yang Su, Yuting Liu

Publikováno v: Frontiers in Cell and Developmental Biology, Vol 8 (2021)
Frontiers in Cell and Developmental Biology

Accumulating evidence shows that exosomal circRNAs reflect the physiological status of donor cells, and various cell reactions are induced after exosomal circRNAs are captured by recipient cells. In this study, qRT-PCR was performed to detect circ-00

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2ae9c55e073530328c395894b6c97ba
https://www.frontiersin.org/articles/10.3389/fcell.2020.585565/full

Reciprocal regulation of DGCR5 and miR-320a affects the cellular malignant phenotype and 5-FU response in pancreatic ductal adenocarcinoma.

Autor: Yong S; Department of Hepatobiliary and Pancreatic Surgery, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu 223300, People's Republic of China., Yabin Y; Department of Hepatobiliary and Pancreatic Surgery, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu 223300, People's Republic of China., Bing Z; Department of Hepatobiliary and Pancreatic Surgery, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu 223300, People's Republic of China., Chuanrong Z; Department of Hepatobiliary and Pancreatic Surgery, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu 223300, People's Republic of China., Dianhua G; Department of Hepatobiliary and Pancreatic Surgery, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu 223300, People's Republic of China., Jianhuai Z; Department of Hepatobiliary and Pancreatic Surgery, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu 223300, People's Republic of China., Weidong Y; Department of Hepatobiliary and Pancreatic Surgery, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu 223300, People's Republic of China., Shuming W; Department of Hepatobiliary and Pancreatic Surgery, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu 223300, People's Republic of China., Ling L; Department of Hepatobiliary and Pancreatic Surgery, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu 223300, People's Republic of China.

Publikováno v: Oncotarget [Oncotarget] 2017 Jun 06; Vol. 8 (53), pp. 90868-90878. Date of Electronic Publication: 2017 Jun 06 (Print Publication: 2017).